AYTU

$1.93-0.52%

AYTU BIOPHARMA, INC

Market Cap

$21M

Live price × SEC shares (Sep 15, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.20

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.4

TTM to Jun 2026 · revenue

P/B

0.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q1 FY2026 Sep 30, 2025	Q2 FY2026 Dec 31, 2025	Q3 FY2026 Mar 31, 2026	Q4 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	13,888	15,165	12,411	16,106	57,570
Cost of revenue	4,702	5,541	4,812	5,697	20,752
Gross profit	9,186	9,624	7,599	10,409	36,818
Research & development	0.00	0.00	0.00	0.00	0.00
Total operating expenses	10,690	11,594	11,663	11,186	45,133
Operating income	(1,504)	(1,970)	(4,064)	(777)	(8,315)
Interest expense	516	560	436	383	1,895
Pretax income	1,965	(10,584)	(5,608)	(4)	(14,231)
Income tax	0.0	0.0	10.0	11.0	21.0
Net income	1,965	(10,584)	(5,618)	(15)	(14,252)
EPS (basic) ($)	0.21	(1.05)	(0.53)		(1.16)
EPS (diluted) ($)	(0.08)	(1.05)	(0.53)
Weighted avg. shares (basic)	9,441	10,036	10,512
Weighted avg. shares (diluted)	19,477	10,036	10,512

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Sep 22, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 63 more quarters, back to Nov 2010, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Sep 22, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Jun 25, 2026 accepted 4:31 PM ET	1.02Agreement terminated	Document SEC ↗
May 13, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Apr 2, 2026 accepted 4:08 PM ET	1.01Material agreement2.02Earnings release3.02Unregistered equity sale3.03Holder rights modified	Document SEC ↗
Feb 3, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Jan 20, 2026 accepted 4:05 PM ET	7.01Reg FD disclosure	Document SEC ↗
Dec 10, 2025 accepted 4:05 PM ET	5.07Shareholder vote	Document SEC ↗
Nov 13, 2025 accepted 4:08 PM ET	2.02Earnings release	Document SEC ↗
Sep 23, 2025 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Aug 7, 2025 accepted 4:20 PM ET	1.02Agreement terminated	Document SEC ↗